| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2009PLoSO...4.5643D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0005643 |
| P932 | PMC publication ID | 2682571 |
| P698 | PubMed publication ID | 19479066 |
| P5875 | ResearchGate publication ID | 26250170 |
| P50 | author | Stefano Di Santo | Q37839349 |
| P2093 | author name string | Christoph Kalka | |
| Iris Baumgartner | |||
| Moritz Wyler von Ballmoos | |||
| Nicolas Diehm | |||
| Zijiang Yang | |||
| Jan Voelzmann | |||
| P2860 | cites work | Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo | Q24648140 |
| Angiogenesis in life, disease and medicine | Q29614539 | ||
| Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 | ||
| Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 | ||
| Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting | Q30319305 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| A noninvasive murine model of hind limb ischemia-reperfusion injury | Q31036688 | ||
| Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. | Q51011615 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
| Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. | Q53574306 | ||
| Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial | Q73069742 | ||
| Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
| The well-tempered vessel | Q73820249 | ||
| Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects | Q73919576 | ||
| Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo | Q74570325 | ||
| Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial | Q74811727 | ||
| Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age | Q81555200 | ||
| The aortic ring model of angiogenesis | Q81931174 | ||
| VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells | Q82264553 | ||
| Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia | Q82862777 | ||
| Monitoring of bone marrow cell homing into the infarcted human myocardium | Q31162853 | ||
| Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells | Q33194273 | ||
| Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy | Q33257976 | ||
| Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris | Q33332841 | ||
| Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction | Q33379564 | ||
| Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures | Q33385959 | ||
| Therapeutic angiogenesis in cardiology using protein formulations | Q34134543 | ||
| Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 | ||
| Gene transfer as a tool to induce therapeutic vascular growth | Q35141791 | ||
| Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. | Q35296718 | ||
| Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? | Q35792010 | ||
| Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs | Q35894577 | ||
| Tissue engineering of angiogenesis with autologous endothelial progenitor cells | Q35908855 | ||
| Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. | Q35985560 | ||
| Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. | Q36014526 | ||
| Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart | Q36294424 | ||
| An SDF-1 trap for myeloid cells stimulates angiogenesis | Q36368581 | ||
| Endothelial progenitor cells in neovascularization of infarcted myocardium | Q37066764 | ||
| Therapeutic angiogenesis for peripheral artery disease: cytokine therapy | Q37115688 | ||
| Emerging hurdles in stem cell therapy for peripheral vascular disease | Q37246834 | ||
| From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. | Q37418551 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization | Q44281968 | ||
| Aging, progenitor cell exhaustion, and atherosclerosis | Q44513172 | ||
| Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogen | Q44665492 | ||
| Gene therapy for arterial disease | Q45871509 | ||
| Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia | Q45886388 | ||
| Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms | Q47248012 | ||
| Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | e5643 | |
| P577 | publication date | 2009-05-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation | |
| P478 | volume | 4 |
| Q38992727 | A defined mix of cytokines mimics conditioned medium from cultures of bone marrow-derived mesenchymal stem cells and elicits bone regeneration |
| Q36821881 | A review on angiogenesis and its assays |
| Q38032602 | Angiogenesis in the infarcted myocardium |
| Q40881340 | Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation |
| Q93006643 | Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction |
| Q34532985 | Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction. |
| Q38114613 | Beyond islet transplantation in diabetes cell therapy: from embryonic stem cells to transdifferentiation of adult cells |
| Q38592199 | Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. |
| Q37780807 | Bone marrow and pancreatic islets: an old story with new perspectives |
| Q33749301 | Bone marrow cell cotransplantation with islets improves their vascularization and function. |
| Q34656322 | Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts |
| Q41820291 | Bone marrow-derived endothelial progenitor cells protect postischemic axons after traumatic brain injury |
| Q60921078 | Calcium mimics the chemotactic effect of conditioned media and is an effective inducer of bone regeneration |
| Q38226693 | Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. |
| Q37338896 | Cell therapy of peripheral arterial disease: from experimental findings to clinical trials |
| Q28484341 | Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity |
| Q38821831 | Chronic stress is associated with reduced circulating hematopoietic progenitor cell number: A maternal caregiving model |
| Q36730596 | Circulating angiogenic cell function is inhibited by cortisol in vitro and associated with psychological stress and cortisol in vivo |
| Q88914445 | Conditioned Medium Protects Dopaminergic Neurons in Parkinsonian Rats |
| Q35755955 | Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis |
| Q36055443 | Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. |
| Q64076706 | Dental derived stem cell conditioned media for hair growth stimulation |
| Q47271643 | Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion-Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction. |
| Q37568644 | Direct contact of umbilical cord blood endothelial progenitors with living cardiac tissue is a requirement for vascular tube-like structures formation. |
| Q42292968 | Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis |
| Q35903365 | Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study |
| Q36109260 | Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes |
| Q36920724 | Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology |
| Q50532130 | Endothelial Progenitor Cell Secretome and Oligovascular Repair in a Mouse Model of Prolonged Cerebral Hypoperfusion. |
| Q90475057 | Endothelial Progenitor Cell-Derived Factors Exert Neuroprotection in Cultured Cortical Neuronal Progenitor Cells |
| Q90268363 | Endothelial Progenitor Cells Conditioned Medium Supports Number of GABAergic Neurons and Exerts Neuroprotection in Cultured Striatal Neuronal Progenitor Cells |
| Q38072175 | Endothelial progenitor cell-based therapy for pulmonary arterial hypertension |
| Q55394119 | Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury. |
| Q50035033 | Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models |
| Q33760892 | Endothelial progenitor cells induce a phenotype shift in differentiated endothelial cells towards PDGF/PDGFRβ axis-mediated angiogenesis |
| Q35061453 | Endothelial progenitor cells promote directional three-dimensional endothelial network formation by secreting vascular endothelial growth factor |
| Q33705402 | Endothelial progenitor cells: therapeutic perspective for ischemic stroke |
| Q54590204 | Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. |
| Q92500962 | Exercise and Cardiovascular Progenitor Cells |
| Q35030632 | Exercise induces stromal cell-derived factor-1α-mediated release of endothelial progenitor cells with increased vasculogenic function. |
| Q89043634 | Exosomes derived from endothelial progenitor cells ameliorate acute lung injury by transferring miR-126 |
| Q28272609 | Exosomes for repair, regeneration and rejuvenation |
| Q92243239 | Exosomes secreted by endothelial progenitor cells improve the bioactivity of pulmonary microvascular endothelial cells exposed to hyperoxia in vitro |
| Q28073078 | Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery |
| Q49183974 | Extracellular vesicles and cardiovascular disease therapy |
| Q34984321 | Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice |
| Q37653826 | Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization |
| Q38981291 | Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells. |
| Q36072383 | Human umbilical mesenchymal stem cells conditioned medium promote primary wound healing regeneration. |
| Q24613344 | Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration |
| Q30423548 | Hypoxic culture and in vivo inflammatory environments affect the assumption of pericyte characteristics by human adipose and bone marrow progenitor cells |
| Q53437323 | Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis. |
| Q35017285 | Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction |
| Q39568333 | Local delivery of VEGF and SDF enhances endothelial progenitor cell recruitment and resultant recovery from ischemia |
| Q39511908 | Mesenchymal Stem Cell Secretome: A Potential Tool for the Prevention of Muscle Degenerative Changes Associated With Chronic Rotator Cuff Tears |
| Q38608414 | Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine |
| Q52567947 | Mesenchymal Stem Cells on Horizon: A New Arsenal of Therapeutic Agents. |
| Q34340690 | Mesenchymal stem cells as feeder cells for pancreatic islet transplants |
| Q36577569 | MicroRNAs as potential novel therapeutic targets and tools for regulating paracrine function of endothelial progenitor cells. |
| Q35176487 | Mononuclear cell secretome protects from experimental autoimmune myocarditis |
| Q38333903 | Neuronal differentiation of adipose-derived stem cells and their transplantation for cerebral ischemia |
| Q33951300 | Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct |
| Q38353261 | Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. |
| Q91864296 | Outgrowth endothelial cells form a functional cerebral barrier and restore its integrity after damage |
| Q37732972 | PKC/NADPH oxidase are involved in the protective effect of pioglitazone in high homocysteine-induced paracrine dyfunction in endothelial progenitor cells |
| Q34518904 | PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors. |
| Q42554972 | Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway |
| Q34494230 | Paracrine mechanisms of stem cell reparative and regenerative actions in the heart |
| Q41660528 | Prospect of stem cell conditioned medium in regenerative medicine. |
| Q34135191 | Regeneration through autologous hypoxia preconditioned plasma |
| Q64065918 | Regenerative Cardiovascular Therapies: Stem Cells and Beyond |
| Q42588105 | Regulating Stem Cell Secretome Using Injectable Hydrogels with In Situ Network Formation |
| Q35195128 | Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner |
| Q54315274 | Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells. |
| Q37847012 | Role of endothelial progenitor cells in the beneficial effects of physical exercise on atherosclerosis and coronary artery disease |
| Q38884138 | Secreted Endothelial Cell Factors Immobilized on Collagen Scaffolds Enhance the Recipient Endothelial Cell Environment |
| Q36233665 | Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation |
| Q35587397 | Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. |
| Q21133599 | Secretome of peripheral blood mononuclear cells enhances wound healing |
| Q34433639 | Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia. |
| Q33746477 | Soluble factors secreted by differentiating embryonic stem cells stimulate exogenous cell proliferation and migration. |
| Q48218729 | Stem Cell-Derived Extracellular Vesicles as a Novel Potential Therapeutic Tool for Tissue Repair |
| Q35517542 | Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series). |
| Q37545373 | Stem cell death and survival in heart regeneration and repair |
| Q38214094 | Stem cell therapy for dermal wound healing |
| Q57767168 | Stem-Cell-Based Therapies for Vascular Regeneration in Peripheral Artery Diseases |
| Q58942288 | Targeting the Cellular “Oxygen Sensors”: Hypoxia Pre-Conditioning and Stabilization of Hypoxia-Inducible Factors |
| Q38802641 | The Cytoprotective Effects of Human Endothelial Progenitor Cell-Conditioned Medium Against an Ischemic Insult Are Not Dependent on VEGF and IL-8. |
| Q35154977 | The secretome of endothelial progenitor cells promotes brain endothelial cell activity through PI3-kinase and MAP-kinase |
| Q35654823 | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
| Q38805228 | Therapeutic angiogenesis using tumor cell-conditioned medium. |
| Q48548216 | Therapeutic effects of human adipose stem cell-conditioned medium on stroke |
Search more.